A carregar...
Sildenafil improves exercise capacity in patients with cystic fibrosis: a proof-of-concept clinical trial
BACKGROUND: Exercise intolerance is a common phenotype observed in patients with cystic fibrosis (CF). Treatment with sildenafil, a phosphodiesterase type 5 (PDE5) inhibitor, has previously been shown to improve exercise capacity (VO(2) peak) in other patient populations. Thus, the present study sou...
Na minha lista:
| Publicado no: | Ther Adv Chronic Dis |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6876159/ https://ncbi.nlm.nih.gov/pubmed/31803404 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040622319887879 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|